Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 6.75M P/E - EPS this Y 53.20% Ern Qtrly Grth -
Income -29.24M Forward P/E -0.32 EPS next Y 26.50% 50D Avg Chg -47.00%
Sales 770.82k PEG - EPS past 5Y - 200D Avg Chg -62.00%
Dividend N/A Price/Book 8.81 EPS next 5Y - 52W High Chg -84.00%
Recommedations 1.50 Quick Ratio 0.80 Shares Outstanding 4.33M 52W Low Chg 27.00%
Insider Own 2.53% ROA -249.22% Shares Float 4.21M Beta 0.23
Inst Own 5.00% ROE -2,741.75% Shares Shorted/Prior 42.72K/17.02K Price 1.56
Gross Margin - Profit Margin - Avg. Volume 338,692 Target Price 25.00
Oper. Margin -3,793.29% Earnings Date Dec 14 Volume 46,612 Change -4.88%
Sonnet BioTherapeutics Holdings News
10/04/22 Sonnet BioTherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
09/26/22 Sonnet BioTherapeutics Appoints Ms. Lori McNeill to the Board of Directors and Formalizes the Company's Business Advisory Committee
09/21/22 Sonnet BioTherapeutics Announces Progress in Two Phase 1 Dose-Escalation Trials of SON-1010
09/16/22 Sonnet BioTherapeutics Announces 1-for-14 Reverse Stock Split
08/15/22 Sonnet BioTherapeutics Provides Fiscal Year 2022 Third Quarter Business and Earnings Update
07/22/22 Sonnet BioTherapeutics Announces Clinical Trial of SON-080 in Patients with Persistent Chemotherapy-Induced Peripheral Neuropathy
07/21/22 Sonnet BioTherapeutics Announces Clinical Trial of SON-1010 in Healthy Volunteers
06/09/22 Sonnet BioTherapeutics Announces Positive Results from a Preclinical Combination Study of SON-1010 with anti-PD1 Checkpoint Inhibition
06/02/22 Sonnet BioTherapeutics Announces Adjournment of Annual Meeting Due to Lack of Quorum
05/10/22 Sonnet BioTherapeutics Provides Fiscal Year 2022 Second Quarter Business and Earnings Update
04/13/22 Sonnet BioTherapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of SON-1010 for Advanced Solid Tumors
04/08/22 Sonnet BioTherapeutics Announces Preclinical Data Supporting Its Bispecific Interleukin Candidates at the American Association for Cancer Research (AACR) 2022 Annual Meeting
03/16/22 Sonnet BioTherapeutics Announces FDA Clearance of Its IND for SON-1010 for the Treatment of Advanced Solid Tumors
02/09/22 Sonnet BioTherapeutics Announces Abstract Accepted for Presentation in a Poster Session at the AACR 2022 Annual Meeting
02/08/22 Sonnet BioTherapeutics Provides Fiscal Year 2022 First Quarter Business and Earnings Update
12/20/21 We're A Little Worried About Sonnet BioTherapeutics Holdings' (NASDAQ:SONN) Cash Burn Rate
12/17/21 Sonnet BioTherapeutics Provides Fiscal Year 2021 Business and Financial Update

Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy. It has a license agreement with New Life Therapeutics PTE, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin 6. Sonnet BioTherapeutics Holdings, Inc. is based in Princeton, New Jersey.

SONN Chatroom

User Image blackhorse14 Posted - 1 hour ago

$SONN Show me what those womenomics do Lori

User Image blackhorse14 Posted - 2 hours ago

$SONN Cmon Lori get daddy his money https://www.youtube.com/watch?v=XXTzm5GtqVo

User Image Golibajje Posted - 4 hours ago

$TENX Merck acquired Acceleron in Sep 2021 for $11.5 billion. Note that it’s lead asset Sotatercept for the Treatment of Pulmonary Arterial Hypertensionis is still in Phase 3 and the results are expected this year end. On the other hand $TENX had stellar results in the previous phases for TNX-201. Efficacy rate is MUCH BETTER than Sotatercept. Just need to wait and watch who will acquire Tenax.. current mkt cap is $4.8m.. has 2 lead candidates in Phase targeting $10 billion market size. Another $LOGC could be!! $ADTX $SONN $ENSC

User Image overlook100 Posted - 16 hours ago

$SONN listen to @Sergeant_VIP he speaks the short.

User Image blackhorse14 Posted - 23 hours ago

$SONN So with these evergreen provisions we experience another 4% dilution going into next year. Am I understanding that correctly?

User Image cemi10 Posted - 23 hours ago

$SONN Are the agos going after reverse split stocks to the positive now. look at $TOPS

User Image intratio Posted - 1 day ago

https://www.intratio.com/stock-forecast/SONN Sonnet BioTherapeutics Holdings Inc Our predictive algorithm judges the market value of this company will lose value in the coming days with a massive stock price increase in the longer term $SONN

User Image Sergeant_VIP Posted - 1 day ago

$SONN good morning everyone, yesterday’s $1 bid compliance was a given when they did a R/S, they still have many other issues to fix has they’re noncompliance with the market cap, equity and have 2 active offerings ($6 million and $25M) since 8/15 showing no SEC filling that it closed. The many positive news they had the pass 2 weeks has done nothing for the stock price has they will continue to dilute on every pop. GL

User Image Jackie_Treehorn Posted - 1 day ago

$SONN do any employees have shares? I thought they gave them up before reverse split for offering.

User Image fla Posted - 1 day ago

$SONN [15s. delayed] filed SEC form 3: Director McNeill Lori: https://s.flashalert.me/DLABP3

User Image cctranscripts Posted - 1 day ago

Sonnet BioTherapeutics Holdings Inc. director just declared ownership of no shares of Sonnet Bi https://www.conferencecalltranscripts.com/summary/?id=11363640 $SONN

User Image blackhorse14 Posted - 1 day ago

$SONN Let's get that stock Lori

User Image Quantisnow Posted - 1 day ago

$SONN 📜 SEC Form 3 filed by new insider Mcneill Lori https://quantisnow.com/i/3493218?utm_source=stocktwits 45 seconds delayed.

User Image Newsfilter Posted - 1 day ago

$SONN Form 3 (initial statement of beneficial ownership of securities) filed with the SEC https://newsfilter.io/a/7c7b1c1deebd9bd872663500c3c9620c

User Image r0ga Posted - 1 day ago

$SONN It’s magic… @Sergeant_VIP If you type "SONN stocktwits" into Google without being logged in, you can see the complete history, even of the people you have blocked. IT knowledge 7th or 8th grade. @all: can someone please tell him, now that he blocked me? Thanks in advance.

User Image r0ga Posted - 1 day ago

$SONN @Sergeant_VIP Why don't you call yourself 'Sergeant_fu**IP' because you're fuc*** annoying and repeat yourself fuc*** day after day ... without one of your announcements being true 🤷 . I unblocked you just to write this to you, in a moment I will block you again.

User Image Sergeant_VIP Posted - 1 day ago

$SONN from todays SEC filling after meeting the $1 bid, they’re still noncompliance with the equity but they’re require to submit a plan before/on October 6th to get an extension. not many stocks get approve for an equity extension while still noncompliance with the Market cap and barely got out the $1 bid. In the case they don’t get approve, they will request a hearing but the SP would already suffer when that happens. HUGE RISK and if approved is not going to pop, if it didn’t pop today on the $1 bid compliance then an equity extension that Carries less weight will have little to no effect. GL

User Image tickeron Posted - 1 day ago

Don't miss this opportunity! $SONN enters a Downtrend as Momentum Indicator dropped below the 0 level on September 16, 2022. View odds for this and other indicators: https://srnk.us/go/4041161

User Image blackhorse14 Posted - 2 days ago

$SONN https://www.youtube.com/watch?v=rUuusqy50yk

User Image Sergeant_VIP Posted - 2 days ago

$SONN @@topstockalerts is trying to pump it, that Twitter pumper has a failed history when trading SONN, his followers need to be aware of the 2 active offerings ($6 million and $25 million) that have not yet close and won’t touch $2 because it will get constantly diluted back down. Don’t listen to pumpers, read the SEC fillings and manage your risk when trading this stock. (Check chart and you’ll see how bad it has been)

User Image Sergeant_VIP Posted - 2 days ago

$SONN on todays SEC filling it saids “not in compliance with shareholders equity” this $1 bid compliance means nothing compare to the equity and market cap compliance. Volume shows nobody is buying this bull trap.

User Image topstockalerts Posted - 2 days ago

$SONN $2+ next

User Image lecorb Posted - 2 days ago

$SONN Sonnet BioTherapeutics regains compliance with Nasdaq's minimum bid price requirement https://seekingalpha.com/news/3888445?source=ansh $SONN

User Image Sergeant_VIP Posted - 2 days ago

$SONN met the $1 bid compliance with a “reverse split” aka cheating (which is why volume still low due to no buyers) but still noncompliance with the “market cap” and “equity” can’t cheat your way out of those. Oh wait you can buy diluting it to death with the 2 active ATM offering

User Image STCKPRO Posted - 2 days ago

$SONN NEW ARTICLE : Sonnet BioTherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement https://www.stck.pro/news/SONN/35338009

User Image cctranscripts Posted - 2 days ago

Sonnet BioTherapeutics Holdings: Sonnet Biotherapeutics Regains Compliance With Nasdaq Minimum https://www.conferencecalltranscripts.com/summary/?id=11361189 $SONN

User Image Last10K Posted - 2 days ago

$SONN just filed with the SEC a Financial Exhibit https://last10k.com/sec-filings/sonn/0001493152-22-027491.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=sonn

User Image fla Posted - 2 days ago

$SONN [15s. delayed] filed form 8-K on October 04, 08:05:38 https://s.flashalert.me/TGzLb

User Image Quantisnow Posted - 2 days ago

$SONN 📜 Sonnet BioTherapeutics Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits https://quantisnow.com/i/3488854?utm_source=stocktwits 45 seconds delayed.

User Image stockilluminati Posted - 2 days ago

$SONN https://www.stockilluminati.com/sonn/filings.php - Sonnet BioTherapeutics Holdings, Inc. - Common Stock files form 8-K today, check out the details.

Analyst Ratings
Chardan Capital Buy Aug 16, 22
BTIG Buy Feb 9, 22
Chardan Capital Buy Dec 20, 21
HC Wainwright & Co. Buy Dec 16, 21
BTIG Buy Sep 15, 21
Chardan Capital Buy Sep 4, 20